Seeing as disrupted lamellar bilayers (LB) may feasibly be the result of a deficiency of IGF-1 and/or a IR mutation, I hypothesize that the results of insufficient bioavailability of IGF-1 and its effects on subsequent pathway signaling likely result in the delayed processing of LB contents as seen in the KP biopsies due to the failure to regulate differentiation as skin cells mature and differentiate at the SC-SG interface
Pros: Setria glutathione (most clinically studied form), liposomal phospholipid delivery, practitioner-trusted brand, hypoallergenic formulation standard
The same technique applies to semaglutide syringe injections and any other subcutaneous peptide protocol
This composite is suited for preclinical models investigating peptide-mediated pathways in regenerative biology
Peptides reproduce what the body already knows to do through its signaling, neurotransmitters, hormones, and enzymes, making them complementary protocols to a healthy lifestyle